/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITES STATES/
MONTREAL, Oct. 25 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC GROUP")
(TSX: "OMG"), a healthcare services company providing facilities and services
to patients and surgeons, is pleased to announce the signing of an eight-year
agreement to open four digestive endoscopy centres within the next 24 months.
The centres will be located in Laval, in Québec City, on the South Shore of
Montréal and in the Gatineau area. The first centre will open its doors in
December 2007 on a new site located at 1575 de l'Avenir Blvd. in Laval.
OPMEDIC GROUP will administer and operate the digestive endoscopy centres
while Laboratoire Médical Biron will promote and market the services of the
four centres. Gastroenterologists and colorectal surgeons from various
hospitals will provide the services.
"The addition of these four digestive endoscopy centres to the existing
one in Montreal, serves to confirm that OPMEDIC GROUP is positioned as a
leader in the implementation and development of private surgical services in
Quebec. There is increasing demand for these services and we are pleased to
provide this essential healthcare service", stated Dr. Pierre St-Michel, CEO
of OPMEDIC GROUP.
About OPMEDIC GROUP
OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".
About LABORATOIRE MEDICAL BIRON
Since it was founded in 1952, Laboratoire Médical Biron, a family-owned
business, has provided personalized, quick and efficient private laboratory
services. The initial objectives have remained unchanged: provide healthcare
professionals with better laboratory services, by rendering accurate and
reliable test results in a much more timely fashion than those available
through a hospital or CLSC.
This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
The Content of this press release has not been approved by nor submitted
to the TSX which assumes no liability therefore.
For further information:
For further information: Paulo Bouça, Vice President Business,
Development and Vice President Finance and Chief Operating Officer, (514)
345-8535, x 2254, email@example.com; Jean-Marc Lachance, Chief Financial
Officer, (514) 345-8535, x 2260, firstname.lastname@example.org